Showing results (131-140 of 144) with videos related to
Sort By:
Pageof 15
Journal of Medicinal Chemistry|November 1, 1975
Synthesis and biological properties of some novel heterocyclic homoprostanoidsA D Bender, C E Berkoff, W G Groves, et al.Journal of Biomedical Materials Research. Part A|November 3, 2005
Synthesis, characterization, and osteocompatibility evaluation of novel alanine-based polyphosphazenesLakshmi S Nair, Duron A Lee, Jared D Bender, et al.Journal of Biomedical Materials Research. Part A|March 6, 2007
Novel low temperature setting nanocrystalline calcium phosphate cements for bone repair: osteoblast cellular response and gene expression studiesSwaminathan Sethuraman, Lakshmi S Nair, Saadiq El-Amin, et al.Journal of Personality Disorders|February 24, 2001
The Collaborative Longitudinal Personality Disorders Study: reliability of axis I and II diagnosesM C Zanarini, A E Skodol, D Bender, et al.Acta Neurologica Scandinavica|May 1, 2001
Normalization of markers for dopamine innervation in striatum of MPTP-lesioned miniature pigs with intrastriatal graftsP Cumming, E H Danielsen, M Vafaee, et al.American Journal of Respiratory Cell and Molecular Biology|January 28, 2012
Role of macrophage chemoattractant protein-1 in acute inflammation after lung contusionMadathilparambil V Suresh, Bi Yu, David Machado-Aranda, et al.Acta Psychiatrica Scandinavica|November 28, 2001
Internal consistency, intercriterion overlap and diagnostic efficiency of criteria sets for DSM-IV schizotypal, borderline, avoidant and obsessive-compulsive personality disordersC M Grilo, T H McGlashan, L C Morey, et al.Headache|February 15, 2013
Expert consensus recommendations for the performance of peripheral nerve blocks for headaches--a narrative reviewAndrew Blumenfeld, Avi Ashkenazi, Uri Napchan, et al.Pediatric Blood & Cancer|March 27, 2026
CPX-351 in High-Risk Relapsed Pediatric Acute Leukemia: Real-World Phase 1 Data Establishing the FDA-Approved DoseJonathan D Bender, Lauren Pommert, Lori R Backus, et al.Transplantation and Cellular Therapy|November 2, 2022
Reduced-Intensity Conditioning Mitigates Risk for Primary Ovarian Insufficiency but Does Not Decrease Risk for Infertility in Pediatric and Young Adult Survivors of Hematopoietic Stem Cell TransplantationJonathan D Bender, Helen Oquendo-Del Toro, Janie Benoit, et al.Pageof 15